Steroid cataracts in children

Article

Paediatric subjects who require frequent steroid therapy are at an increased risk of developing amblyopia due to cataracts, according to a study published online ahead of print by Pediatrics International, the official English language publication of the Japan Pediatric Society.

Paediatric subjects who require frequent steroid therapy are at an increased risk of developing amblyopia due to cataracts, according to a study published online ahead of print by Pediatrics International, the official English language publication of the Japan Pediatric Society.

Yasuhito Nerome, MD of the Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan and colleagues evaluated risk factors for the formation of cataracts in paediatric subjects.

The researchers found a positive association between cataract formation and intravenous methylprednisone pulse (IVMP) therapy in subjects aged ≤12 years. No relationship to cataract formation was found to exist with either the doses (cumulative or daily) of steroids used or with patient gender.

Thus the researchers recommended that, since corticosteroid use is associated with cataract formation in paediatric subjects, these patients be examined by ophthalmologists frequently, to reduce the risk of amblyopia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.